Screener
PPH vs IDNA
VanEck Pharmaceutical ETF vs iShares Genomics Immunology and Healthcare ETF
Key differences
- PPH costs 0.11% less per year.
- PPH is significantly larger than IDNA — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, PPH has delivered higher annualized returns.
- PPH has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| PPH | IDNA | |
|---|---|---|
| Annual cost (TER) | 0.36% | 0.47% |
| Fund size (AUM) | $966M | $160M |
| Since | 2011 | 2019 |
| Dividend yield | 2.12% | 1.05% |
| Asset class | equity | equity |
| Region | north america | — |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +24.5% | +49.2% |
| CAGR 3Y | +12.6% | +8.0% |
| CAGR 5Y | +9.8% | -7.5% |
| Sharpe 3Y | 0.63 | 0.29 |
| Volatility 1Y | 17.07% | 24.43% |
| Max drawdown | -29.70% | -68.26% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PPH and IDNA
Explore further